Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Medical Treatments

Health written question – answered on 25th February 2013.

Alert me about debates like this

Photo of Paul Beresford Paul Beresford Conservative, Mole Valley

To ask the Secretary of State for Health what estimate (a) his Department, (b) the National Institute for Health and Clinical Excellence and (c) the NHS Technology Adoption Centre have made of the number of patients who could benefit from oesophageal doppler monitoring and similar fluid management monitoring technologies.

Photo of Daniel Poulter Daniel Poulter The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Clinical Excellence (NICE)'s costing template and report, which accompanies its medical technologies guidance on the CardioQ-ODM oesophageal doppler monitor, states that adoption of intra-operative fluid management across the NHS in England could benefit 10% of all surgical patients. Using figures for 2009-10 this equates to 837,145 people per year. The costing template and report are available at:

A comprehensive technology adoption pack has been produced by the NHS Technology Adoption Centre (NTAC) on behalf of the Department. This lists 77,560 procedures carried out in England annually in which there is most evidence for the use of intra-operative fluid management. The adoption pack is available at:

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.